Sanjeev Madaan

Consultant Urological Surgeon & Lead Cancer Clinician

Darent Valley Hospital, Dartford; Visiting Professor, Canterbury Christ Church University; Chairman Urology TSSG, Kent & Medway Cancer Alliance; Speciality Lead for Urology Cancer Research, CRN Kent, Surrey & Sussex, Expert Advisor to NICE.

Latest Contribution

History of prostate biopsy – part 2

1 September 2018 | | Basic Science Research, Technological Developments, Urologic Oncology

For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...

History of prostate biopsy – part 1

1 January 2018 | | Basic Science Research, Technological Developments, Urologic Oncology

Part 2 of this topic is available here. Prostate biopsy (PBx) to exclude cancer has been part of clinical practice since the beginning of the 20th Century. PBx techniques have evolved over time to optimally address some of the unique...

Small renal masses – diagnosis and management

1 January 2017 | | Urologic Oncology

Renal cancer is the eighth most common cancer in the UK and accounts for about 3% of all new cancer diagnoses [1]. The incidence rates are steadily rising, with the highest rates being in older men and women. This rise...